“We are that source of truth for helping our clients identify which individuals and health care professionals or organizations they should work with,” begins Ariel Katz, CEO, and co-founder of H1. New York-based H1 arms healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases. The company has developed a platform that connects health care and life science professionals and companies. “If one can find a principal investigator who has done a successful clinical trial in an adjacent space, pharma companies can improve their chances for success,” states Katz.
The H1 platform provides real-time data to support the end-to-end therapeutic development process from product development to product launch, helping companies make smart scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, Key Opinion Leaders scholarly content, markets, competitors, and new opportunities through research grounded in actual data and clinical findings.
A Brief History
With a motto to build a business that profiles every single researcher and healthcare professional globally, Katz aimed to construct an accurate account of the professional ecosystem that could be a massive help to businesses as diverse as pharmaceutical companies, hospitals, insurers, and, eventually, consumers.
For Katz, it was the continuation of a longstanding mission to create transparency for previously opaque data sets. Katz sold his first company, Research Connection That company was designed to uncover the research underway at universities worldwide so students could see where they should apply for undergraduate and graduate studies.
After the sale, the young entrepreneur went on a vacation to India, and it was via that trip that he met his co-founder Ian Sax. The two men became friends and collaborated on projects — including a dataset of public company executives. Conversations between the two soon hit upon the lack of transparency around what research was happening at which universities and which clinical trials were underway at which hospitals.
A visible network of experts, the two men thought, would go a long way toward solving a number of the healthcare industry’s seemingly intractable problems.
We Are Heavily Driven By What Our Clients And Users Need As We Grow Our Businesses Together
Pharma, biotech, and medical devices spend $30 billion per year, partnering with researchers and hospitals. If they could sort and search and rank and analyze researchers, it would help reduce the cost and solve the problem. While Katz believed the transparency could help solve some healthcare drug development and discovery problems, he was also wary about creating others.
The H1 Platform
One of its kind, the H1 platform can be used to find, engage, and keep up to date with healthcare professionals, and this powerful a solution in the market didn’t exist before. It is a truly global platform that consists of health care professionals from all around the world, such as China, Taiwan, Japan, Singapore, Brazil, Argentina, Canada, US, and all of the EU. The platform can be viewed in the local languages of those countries as well.
H1 integrates to every leading CRM (SalesForce, Dynamics), instantly making it easier and faster to track, analyze, and glean insights into the people, organizations, and findings shaping the healthcare market. Within the healthcare industry, H1 focuses on pharma, biotech, medical devices, hospitals, health systems, and medical schools. For example, within pharma, there are several use cases for the data available on this platform, including identifying healthcare professionals for clinical trials to read the latest publication by leading healthcare professionals.
The data set underlying H1’s platform comprises over 9 million researchers, physician, pharmacist, nurse, and administrator profiles across 70 countries, 16,000 health care organizations, 160 million peer-reviewed publications (and citation counts), 350,000 clinical trials, 2 billion procedures, 3 billion diagnoses, 700 medical societies, and proprietary scholarly metrics that are kept up to date weekly. The company claims to capture information on over 95 percent of health care professional-patient interactions in the US, including their speaking history, which can be used to identify treatment leaders and understand their procedural and diagnostic tendencies.
H1 customers can search by relevant codes to identify the physicians doing work directly related to their service line. Every professional on the platform has a profile listing their publications, trials, payments, congresses, social media history, and more, as well as contact information including email, phone number, and mailing address.
"We Are That Source Of Truth For Helping Our Clients Identify Which Individuals And Health Care Professionals Or Organizations They Should Work With"
Combating COVID-19 Crisis
H1 recently began offering free access to professionals on its platform in need of medical supplies to combat the ongoing pandemic. H1 has extended free access to HCPs in need of medical supplies during the current pandemic to bring medical providers together to source medical supplies, share medical information, and understand the newest research.
H1 understands the added stress of sourcing medical supplies and information during the COVID-19 pandemic and wants to help in every way possible. “With our platform, you can search which doctors are treating COVID-19 patients. Once you find the doctor, you’ll receive pertinent information to their medical cases and have the opportunity to reach out and collaborate,” adds Katz.
Delivering Real Results
For instance, a leading pharma company wanted to identify the top healthcare organizations in the US, working on Nonsmall cell lung cancer (NSCLC). The client could not understand which institutions were undertaking research in NSCLC and which pharma companies were collaborating with those same institutions. Moreover, they failed to identify the right professionals from those institutions to collaborate with regarding NSCLC. Using H1 platform, the client was finally able to locate every single institution in the US involved in NSCLC. From seeing patients to academic research, the client discovered every single pharma company working with such institutions to clinical trial activity. H1 uncovered proper health care professionals at those institutions that the client should engage with and transform their strategy in regards to NSCLC. “That is how we facilitate the connection between pharmaceutical companies and health care professionals,” adds Katz.
What Lies Ahead
H1 has successfully developed technology that surfaces hard-to-find healthcare data and arms clients with that data to make better and faster data-driven decisions along their development pipeline. H1 has a diverse team with varied skill sets contributing to one similar mission that ultimately enables them to understand user problems and solve those creatively and successfully. With an agile mindset, the team gathers at regular intervals, and they stay updated on all the information collected through clients and users and strategize accordingly to grow their business.
With significant rounds of funding, H1 has raised close to $13 million to date. The company aims to take its business globally and develop applications for the pharmaceutical industry, care providers, and consumers. “We are heavily driven by what our clients and users need as we grow our businesses together,” concludes Katz.